Engaged ownership

The LEO Foundation is a commercial foundation with the primary purpose of ensuring the continuance of the global pharmaceutical company LEO Pharma A/S.

In accordance with our charter, the LEO Foundation is the permanent controlling owner of LEO Pharma, and we exercise engaged ownership to support the company’s long-term development and success.

The LEO Group

The LEO Group consists of the LEO Foundation, LEO Holding A/S and LEO Pharma A/S, including its Danish and international subsidiaries (collectively LEO Pharma Group).

LEO Pharma A/S

The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.


Founded in 1908


Headquartered in Denmark with a global team of 6,000 people


Serving 93 million patients in more than 130 countries

A clear charter

The charter sets the overall purpose and objective of the Foundation and defines how it should be governed.​

In accordance with the charter, the Foundation’s primary purpose and objective is to ensure the continuance of LEO Pharma.

The charter defines the Foundation’s philanthropic field as support to research within medicine, chemistry and pharmacy​.